Pricing and reimbursement of medicinal products in Europe

Conférence Bleue, the most prestigious European network of lawyers specialized in pharmaceutical and health care law, has published in June 2015 a guide on the current status of pricing and reimbursement of medicinal products for human use in the main EU jurisdictions and some other jurisdictions close to the EU that are commonly of interest to companies. The guide answers the most common questions about pricing and reimbursement across multiple jurisdictions, from the p... Conférence Bleue, the most prestigious European network of lawyers specialized in pharmaceutical and health care law, has published in June 2015 a guide on the current status of pricing and reimbursement of medicinal products for human use in the main EU jurisdictions and some other jurisdictions close to the EU that are commonly of interest to companies. The guide answers the most common questions about pricing and reimbursement across multiple jurisdictions, from the procedures of reimbursement to the new strategies to control the expenditure of rare diseases’ treatments. JAUSAS is the Spanish member of Conférence Bleue, which was founded in 1997 and is composed by 25 law firms. Our lawyers Héctor Jausàs and Maria Cedó has written the Spanish chapter. You will find more information of Conférence Bleue on its website www.conference-bleue.com